REVIEW OF CURRENT METHODS OF REHABILITATION OF COVID-19 PROFILE PATIENTS USING RETROSPECTIVE AND CONTEMPORARY STUDIES OF THE DISEASE DOI Open Access

O.M. Uryasev,

N.A. Rondaleva,

A.P. Malchuk

и другие.

Современные проблемы науки и образования (Modern Problems of Science and Education), Год журнала: 2023, Номер №6 2023, С. 151 - 151

Опубликована: Янв. 1, 2023

ОБЗОР АКТУАЛЬНЫХ МЕТОДОВ РЕАБИЛИТАЦИИ ПАЦИЕНТОВ ПРОФИЛЯ COVID-19 С ИСПОЛЬЗОВАНИЕМ РЕТРОСПЕКТИВЫ И СОВРЕМЕННЫХ ИССЛЕДОВАНИЙ ЗАБОЛЕВАНИЯУрясьев О.М

Язык: Русский

2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee DOI Open Access
Antoine Verger, Henryk Barthel, Nelleke Tolboom

и другие.

European Journal of Nuclear Medicine and Molecular Imaging, Год журнала: 2022, Номер 49(11), С. 3599 - 3606

Опубликована: Июль 16, 2022

Язык: Английский

Процитировано

28

Transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric symptoms of long COVID DOI Creative Commons
Monika Klírová,

Andrea Adamová,

Nina Biačková

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Янв. 25, 2024

Abstract The study aimed to assess the efficacy of transcranial direct current stimulation (tDCS) in treatment neuropsychiatric (NP) symptoms post-acute sequelae SARS-CoV-2 infection (PASC), known as long COVID. A double-blind, randomized, sham-controlled compared and safety prefrontal cortex active tDCS sham-tDCS treating NP-PASC. Patients diagnosed with NP-PASC, a Fatigue Impact Scale (FIS) score ≥ 40, were eligible for study. Twenty sessions administered within four weeks, continuous, end-of-treatment, follow-up measurements. primary outcome was change FIS at analyzed intention-to-treat population. Data from 33 patients assigned (n = 16) or 17) analyzed. After treatment, decrease more pronounced sham than group, yet intergroup difference insignificant (11.7 [95% CI −11.1 34.5], p 0.6). Furthermore, no significant differences observed regarding anxiety, depression, quality life, cognitive performance. small cohort sample, baseline scores between groups (non-stratified randomization), chosen parameters may have influenced our findings. However, it might also be possible that expected mechanism action is insufficient treat these conditions.

Язык: Английский

Процитировано

7

Psychological and Cognitive Effects of Long COVID: A Narrative Review Focusing on the Assessment and Rehabilitative Approach DOI Open Access
Rosaria De Luca, Mirjam Bonanno, Rocco Salvatore Calabrò

и другие.

Journal of Clinical Medicine, Год журнала: 2022, Номер 11(21), С. 6554 - 6554

Опубликована: Ноя. 4, 2022

Long COVID is a clinical syndrome characterized by profound fatigue, neurocognitive difficulties, muscle pain, weakness, and depression, lasting beyond the 3–12 weeks following infection with SARS-CoV-2. Among symptoms, psychiatric sequelae, including attention memory alterations, as well anxiety depression have become major targets of current healthcare providers given significant public health impact. In this context, assessment tools play crucial role in early screening cognitive alterations due to COVID. others, general tools, such Montreal Cognitive assessment, more specific ones, State Trait Inventory Fatigue Digit Span, may be help investigating main alterations. Moreover, appropriate neurorehabilitative programs using methods techniques (conventional and/or advanced) through multidisciplinary team are required treat COVID-19-related behavioral abnormalities. narrative review, we sought describe symptoms provide some advice for treatment

Язык: Английский

Процитировано

24

Enhanced External Counterpulsation Improves Cognitive Function of Persons with Long COVID DOI
Mohanakrishnan Sathyamoorthy,

Rajkumar J. Sevak,

J. Cabrera

и другие.

American Journal of Physical Medicine & Rehabilitation, Год журнала: 2024, Номер unknown

Опубликована: Янв. 3, 2024

ABSTRACT Objective To determine the effects of Enhanced External Counterpulsation (EECP) in patients with long COVID and objectively assessed cognitive impairment. Design A retrospective evaluation referred for EECP, sequela, having completed an objective digital assessment before after therapy. Patients had either impairment (CI) or no (NCI) at baseline. We changes composite score using multi-factor ANOVA. Multiple linear logistic regression analyses were conducted to evaluate several independent variables. Results 80 (38 CI vs 42 NCI) included analyses. All baseline characteristics well matched. There was significant improvement post-EECP those notable documented safety concerns. Conclusion This is first study showing that EECP led functioning defined Although a lack negative control group limitation this study, appears be highly safe effective potential widespread application.

Язык: Английский

Процитировано

5

Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches DOI Creative Commons
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang

и другие.

CNS Neuroscience & Therapeutics, Год журнала: 2025, Номер 31(3)

Опубликована: Март 1, 2025

ABSTRACT Background The COVID‐19 pandemic has left an indelible mark on the world, with mounting evidence suggesting that it not only posed acute challenges to global healthcare systems but also unveiled a complex array of long‐term consequences, particularly cognitive impairment (CI). As persistence post‐COVID‐19 neurological syndrome could evolve into next public health crisis, is imperative gain better understanding intricate pathophysiology CI in patients and viable treatment strategies. Methods This comprehensive review explores management across phases COVID‐19, from infection Long‐COVID, by synthesizing findings clinical, preclinical, mechanistic studies identify key contributors CI, as well current therapeutic approaches. Results Key mechanisms contributing include persistent neuroinflammation, cerebrovascular complications, direct neuronal injury, activation kynurenine pathway, psychological distress. Both pharmacological interventions, such anti‐inflammatory therapies agents targeting neuroinflammatory pathways, non‐pharmacological strategies, including rehabilitation, show promise addressing these challenges. Although much derived preclinical animal studies, provide foundational insights potential Conclusion By knowledge, this highlights importance COVID‐19‐related offers actionable for mitigation recovery community continues grapple pandemic's impact.

Язык: Английский

Процитировано

0

Acute and long-term neurological manifestations of Covid-19: insights from virology and neurology DOI Creative Commons
Kirolos Eskandar

Deleted Journal, Год журнала: 2025, Номер 16(1), С. 3 - 13

Опубликована: Март 30, 2025

Introduction This literature review examines the profound impact of Covid-19, caused by SARS-CoV-2, on nervous system. While virus is predominantly associated with respiratory complications, emerging evidence highlights its strong neurotropic potential, leading to a broad spectrum neurological disorders. explores convergence virology and neurology, emphasizing both acute long-term consequences disease. Methods A systematic following PRISMA guidelines was conducted using databases such as PubMed, Scopus, Web Science. Studies were selected based their relevance pathophysiology, clinical presentations, prolonged effects Covid-19. Preference given peer-reviewed research, including meta-analyses case reports published between 2020 2024. Results The identifies various pathways through which SARS-CoV-2 affects system, direct neuroinvasion systemic inflammatory responses. Acute conditions encephalitis, stroke, Guillain-Barré syndrome have been frequently reported, while chronic complications include cognitive dysfunction, neurodegenerative disorders, psychiatric disturbances. These findings highlight intricate enduring burden Conclusion Neuro-Covid presents an ongoing challenge in post-pandemic landscape. deeper understanding implications essential for enhancing patient management shaping future research directions. importance increased vigilance multidisciplinary strategy effectively address complex evolving Covid-19-related

Язык: Английский

Процитировано

0

Neuropsychology practice guidance for the neuropsychiatric aspects of Long COVID DOI
Christine Koterba, Ciaran Considine, Jacqueline Becker

и другие.

The Clinical Neuropsychologist, Год журнала: 2024, Номер unknown, С. 1 - 29

Опубликована: Авг. 23, 2024

The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has had a profound global impact on individual health and well-being in adults children. While most fully recover from COVID-19, relatively large subgroup continues to experience persistent physical, cognitive, emotional/behavioral symptoms beyond the initial infection period. World Health Organization termed this phenomenon "Post-COVID-19 Condition" (PCC), better known as "Long COVID." Due cognitive psychosocial symptoms, neuropsychologists often assess recommend treatment for individuals with Long COVID. However, guidance neuropsychologists' involvement clinical care, policy-making, research not yet been developed. authors of manuscript convened address critical gap develop working patients presenting

Язык: Английский

Процитировано

3

“Long Haulers” DOI

Denyse Lutchmansingh,

Jean Paul Higuero Sevilla,

Jennifer D. Possick

и другие.

Seminars in Respiratory and Critical Care Medicine, Год журнала: 2023, Номер 44(01), С. 130 - 142

Опубликована: Янв. 16, 2023

Abstract Post-COVID conditions continue to afflict patients long after acute severe respiratory syndrome-coronavirus-2 (SARS CoV-2) infection. Over 50 symptoms across multiple organ systems have been reported, with pulmonary, cardiovascular, and neuropsychiatric sequelae occurring most frequently. Multiple terms used describe post-COVID including COVID, long-haul postacute coronavirus disease 2019 (COVID-19), of SARS-CoV-2 infection, long-term effects chronic COVID-19; however, standardized assessments treatment algorithms for generally lacking. This review discusses the epidemiology risk factors provides a general overview diagnostic assessment specific manifestations. Data derived from multitude observational studies scientific investigations into pathogenesis are providing clearer understanding distinct phenotypes conditions. Insight gained these ongoing interventional trials continues lead development clinical protocols directed toward improving COVID-19 survivors' quality life preventing or reducing morbidity.

Язык: Английский

Процитировано

8

Cognitive impairment, anxiety and depression: a map of Cochrane evidence relevant to rehabilitation for people with post COVID-19 condition DOI Creative Commons
Claudio Cordani, Vanessa M. Young, Chiara Arienti

и другие.

European Journal of Physical and Rehabilitation Medicine, Год журнала: 2022, Номер 58(6)

Опубликована: Дек. 19, 2022

Currently, no evidence exists on specific treatments for post COVID-19 condition (PCC). However, rehabilitation interventions that are effective similar symptoms in other health conditions could be applied to people with PCC. With this overview of systematic reviews mapping, we aimed describe the Cochrane proposed cognitive impairment, anxiety and depression different can relevant

Язык: Английский

Процитировано

11

Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic DOI Creative Commons
Christina Reppas‐Rindlisbacher, Alexa Boblitz, Robert Fowler

и другие.

JAMA Network Open, Год журнала: 2023, Номер 6(8), С. e2327750 - e2327750

Опубликована: Авг. 7, 2023

The COVID-19 pandemic caused large disruptions to health care for hospitalized older adults. incidence and management of delirium may have been affected by high rates infection, staffing shortages, overwhelmed hospital capacity, changes visitor policies.

Язык: Английский

Процитировано

6